AstraZeneca: No Talks With Trump On Emergency Use Authorization For COVID-19 Vaccine

Politicization Could Undermine Public Faith In Vaccine

Reports come as tensions around the independence of the US FDA mount, and data readouts from the first vaccines could emerge before US election day on 3 November.

Astrazeneca
A readout from Oxford University's Phase III study could be ready as early as September

AstraZeneca PLC has denied speculation that it is in negotiations with the White House about a potential emergency use authorization of its COVID-19 vaccine candidate ahead of the US presidential elections in November.

The company has responded to claims made in the Financial Times on 23 August, the same day that the US...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet